MedTrace Logo

Paravertebral Catheter for Lung Transplant

NCT02380417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2015-03-05

No results posted yet for this study

Summary

This is a prospective observational trial of patient undergoing lung transplantation who have a thoracic paravertebral catheter(s) placed for postoperative pain control. Patients pain scores and opioid use were evaluated for 7 days after placement as well as any complications, opioid adverse events, and length of stay.

Conditions

  • Acute Pain

Interventions

PROCEDURE

paravertebral catheter placement

a thoracic paravertebral catheter was placed and connected to an elastomeric pump with a continuous infusion of 0.2% ropivacaine

DRUG

0.2% ropivacaine

0.2% ropivacaine was infused through the elastomeric device

DEVICE

Elastomeric pump

An elastomeric pump was connected to the paravertebral catheter

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380417 on ClinicalTrials.gov